Half-Year Liquidity Contract Statement for Valerio Therapeutics
05 Agosto 2024 - 12:18PM
Business Wire
Regulatory News:
Under the liquidity contract entered into between VALERIO
THERAPEUTICS (Paris:ALVIO) and Kepler Cheuvreux, the following
resources appeared on the liquidity account on June 30, 2024:
- 392,365 shares - € 144,905.34 - Number of executions on buy
side on semester: 108 - Number of executions on sell side on
semester: 95 - Traded volume on buy side on semester: 128,013
shares for € 15,133.69 - Traded volume on sell side on semester:
103,822 shares for € 12,955.33
As a reminder:
- the following resources appeared on the last half year
statement on 31 December 2023 on the liquidity account:
- 368,174 shares - € 144,918.05 - Number of executions on buy
side on semester: 324 - Number of executions on sell side on
semester: 244 - Traded volume on buy side on semester: 304,205
shares for € 69,976.87 - Traded volume on sell side on semester:
223,191 shares for € 56,117.81
- the following resources appeared on the liquidity account when
the activity started:
- 87,612 shares - € 196,423.24
The implementation of this report is carried out in accordance
with AMF Decision N°2021-01 of June 22, 2021 renewing the
implementation of liquidity contracts for shares as an accepted
market practice.
Public limited company with a capital of €
21,610,998.20 Registered office: 49 boulevard du Général Martial
Valin - 75015 Paris 410 910 095 R.C.S. on the Paris Trade and
Companies Register
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240805263863/en/
Valerio Therapeutics Investor Relations
investors@valeriotx.com tel : +33 (0) 1 70 38 33 99
Valerio Therapeutics (EU:ALVIO)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Valerio Therapeutics (EU:ALVIO)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024